The Predictive Value of Complement C3 in Patients With Advanced Gastric Cancer

• Status: Completed
• Trial end date: 2015-04-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is designed to investigate whether complement C3 depletion is associated with poor short-term outcomes in postoperative patients with gastric cancer.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: First Affiliated Hospital, Sun Yat-Sen University
• Treatments: Complement C3; Complement System Proteins; Oxaliplatin

Criteria

Inclusion Criteria:

• Pathological diagnosis of gastric adenocarcinoma

• Radical operation and adjuvant chemotherapy endurable

• Informed consent approved

Exclusion Criteria:

• Age <18 or >75 years old

• Pregnancy or lactating woman

• Any primary diagnosis other than gastric cancer

• Confirmed complement deficiency due to immunity dysfunction or other disease

• Required blood transfusion, plasmapheresis, or emergent operation